O6-alkylguanine-DNA alkyltransferase: role in carcinogenesis and chemotherapy.
| dc.contributor.author | Margison, Geoffrey P | |
| dc.contributor.author | Santibanez-Koref, Mauro F | |
| dc.date.accessioned | 2009-11-05T17:27:39Z | |
| dc.date.available | 2009-11-05T17:27:39Z | |
| dc.date.issued | 2002-03 | |
| dc.identifier.citation | O6-alkylguanine-DNA alkyltransferase: role in carcinogenesis and chemotherapy. 2002, 24 (3):255-66 Bioessays | en |
| dc.identifier.issn | 0265-9247 | |
| dc.identifier.pmid | 11891762 | |
| dc.identifier.doi | 10.1002/bies.10063 | |
| dc.identifier.uri | http://hdl.handle.net/10541/85476 | |
| dc.description.abstract | The DNA in human cells is continuously undergoing damage as consequences of both endogenous processes and exposure to exogenous agents. The resulting structural changes can be repaired by a number of systems that function to preserve genome integrity. Most pathways are multicomponent, involving incision in the damaged DNA strand and resynthesis using the undamaged strand as a template. In contrast, O(6)-alkylguanine-DNA alkyltransferase is able to act as a single protein that reverses specific types of alkylation damage simply by removing the offending alkyl group, which becomes covalently attached to the protein and inactivates it. The types of damage that ATase repairs are potentially toxic, mutagenic, recombinogenic and clastogenic. They are generated by certain classes of carcinogenic and chemotherapeutic alkylating agents. There is consequently a great deal of interest in this repair system in relation to both carcinogenesis and cancer chemotherapy. | |
| dc.language.iso | en | en |
| dc.subject | Cancer | en |
| dc.subject.mesh | Alkylating Agents | |
| dc.subject.mesh | Animals | |
| dc.subject.mesh | Carcinogens | |
| dc.subject.mesh | Cell Transformation, Neoplastic | |
| dc.subject.mesh | DNA Repair | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Neoplasms | |
| dc.subject.mesh | O(6)-Methylguanine-DNA Methyltransferase | |
| dc.title | O6-alkylguanine-DNA alkyltransferase: role in carcinogenesis and chemotherapy. | en |
| dc.type | Article | en |
| dc.contributor.department | CRC Carcinogenesis Group, Paterson Institute for Cancer Research, Manchester, UK. | en |
| dc.identifier.journal | BioEssays | en |
| html.description.abstract | The DNA in human cells is continuously undergoing damage as consequences of both endogenous processes and exposure to exogenous agents. The resulting structural changes can be repaired by a number of systems that function to preserve genome integrity. Most pathways are multicomponent, involving incision in the damaged DNA strand and resynthesis using the undamaged strand as a template. In contrast, O(6)-alkylguanine-DNA alkyltransferase is able to act as a single protein that reverses specific types of alkylation damage simply by removing the offending alkyl group, which becomes covalently attached to the protein and inactivates it. The types of damage that ATase repairs are potentially toxic, mutagenic, recombinogenic and clastogenic. They are generated by certain classes of carcinogenic and chemotherapeutic alkylating agents. There is consequently a great deal of interest in this repair system in relation to both carcinogenesis and cancer chemotherapy. |